Artwork

Inhoud geleverd door International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Dr. Joel Palefsky: The Father of Anal Dysplasia Screening, Treatment, and Research

35:39
 
Delen
 

Manage episode 407390346 series 3561422
Inhoud geleverd door International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Dr. Joel Palefsky discusses his long career and trailblazing research. He discusses the cervical model which informed his research. He talks of the success of his groundbreaking ANCHOR study, a large clinical trial that found, as with the cervix, treating anal precancerous growths greatly reduces the chance of developing cancer.

As his work evolved, Palefsky’s vision expanded. He saw a need to create a way for scientists and clinicians in this young field to interact and collaborate. The Anal Cancer Foundation and the Farrah Fawcett Foundation graciously stepped up to help financially, and IANS was born.

Dr. Palefsky sees ANCHOR as only the beginning of creating innovations in patient care. He expresses hopefulness that in the future the 500,000 specimens collected during the study will help define HPV types and identify which will regress and which remain persistent.

His work was not done for prestige, but his groundbreaking study has brought him that.

Dr. Palefsly ends with a reflection on his life’s work, hopes and dreams.

  continue reading

10 afleveringen

Artwork
iconDelen
 
Manage episode 407390346 series 3561422
Inhoud geleverd door International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door International Anal Neoplasia Society (IANS), Eric Ganz, MD, Mary-Jo Murphy, and RN of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Dr. Joel Palefsky discusses his long career and trailblazing research. He discusses the cervical model which informed his research. He talks of the success of his groundbreaking ANCHOR study, a large clinical trial that found, as with the cervix, treating anal precancerous growths greatly reduces the chance of developing cancer.

As his work evolved, Palefsky’s vision expanded. He saw a need to create a way for scientists and clinicians in this young field to interact and collaborate. The Anal Cancer Foundation and the Farrah Fawcett Foundation graciously stepped up to help financially, and IANS was born.

Dr. Palefsky sees ANCHOR as only the beginning of creating innovations in patient care. He expresses hopefulness that in the future the 500,000 specimens collected during the study will help define HPV types and identify which will regress and which remain persistent.

His work was not done for prestige, but his groundbreaking study has brought him that.

Dr. Palefsly ends with a reflection on his life’s work, hopes and dreams.

  continue reading

10 afleveringen

Toate episoadele

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding